Preparation of pyrimidine intermediates useful for the manufacture of macitentan

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9422249
APP PUB NO 20160052891A1
SERIAL NO

14780383

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a new synthetic intermediate, namely the compound of formula I-2

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACTELION PHARMACEUTICALS LTDGEWERBESTRASSE 16 ALLSCHWIL 4123

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abele, Stefan Allschwil, CH 16 74
Funel, Jacques-Alexis Allschwil, CH 7 19
Schindelholz, Ivan Allschwil, CH 8 31

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 23, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00